Protecting Men From Prostate Cancer
Related Videos:
02:35
Leading robotic prostate cancer surgeon, Dr. David Samadi, comments on study from Duke University regarding the comparison of surgical outcomes from robotic prostatectomy surgery and traditional, open surgery. Dr. Samadi points out that the study involved few patients at an institution with lower surgical volume and unknown levels of surgeon expertise.
01:54
Mt. Sinai Medical Center's Dr. David Samadi gives a glimpse into one man's choice to have robotic prostatectomy surgery following his early prostate cancer diagnosis.
Robotic prostate removal surgery is the only procedure that gives complete information about how much prostate cancer is present, what the margins are, and the status of the lymph nodes and seminal vesicles. Seed radiation, beam radiation, HIFU, and cryogenics do not provide these details about prostate cancer.
Robotic prostate removal surgery is the only procedure that gives complete information about how much prostate cancer is present, what the margins are, and the status of the lymph nodes and seminal vesicles. Seed radiation, beam radiation, HIFU, and cryogenics do not provide these details about prostate cancer.
01:18
Top robotic prostate cancer surgeon, Dr. David Samadi, breaks down the most important reasons to choose robotic surgery for prostate cancer. He explains that removing the prostate through robotic prostatectomy involves the complete removal of all prostatic tissue and lymph nodes.
This site requires Flash Player version 10.1 or higher. You can install the latest version of the Adobe Flash Player by clicking here.
Views: 16
Channel name: NBC
Protecting Men From Prostate Cancer
September is Prostate Cancer Awareness Month. Prostate cancer is a disease that affects 1 out of every 6 men. Early prostate cancer detection and treatment can mean the difference between life and death. The good news from Dr. David Samadi, Chief of Robotics and Minimally Invasive at Surgery at the Mount Sinai Medical Center, is that he's able to provide invaluable recommendations and guidance about prostate cancer screening and treatment. The average age of men with prostate cancer is 69, but there are several other factors (including genetic history and ethnicity) that can contribute to the likelihood of men developing this disease.